Drugs / Armored Dendritic Cell Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07479667 | Feb 2026 → Dec 2028 expected | — | Shanghai Cell Therapy Group Co.,Ltd | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Armored Dendritic Cell Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07479667 ↗ |
| Modality | Cell therapy | “Armored dendritic cells are administered via multiple subcutaneous injections.” NCT07479667 ↗ |
| Route | Subcutaneous | “multiple subcutaneous injections” NCT07479667 ↗ |